» Authors » P C Hopewell

P C Hopewell

Explore the profile of P C Hopewell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 168
Citations 4226
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaisson R, Hopewell P
IJTLD Open . 2024 Aug; 1(8):335-337. PMID: 39131593
No abstract available.
2.
Kato-Maeda M, Choi J, Jarlsberg L, Grinsdale J, Higashi J, Kawamura L, et al.
Int J Tuberc Lung Dis . 2019 May; 23(4):433-440. PMID: 31064622
<sec id="st1"> <title>SETTING</title> The household and non-household contacts of patients with tuberculosis (TB) face varying degrees of risk of infection by . </sec> <sec id="st2"> <title>OBJECTIVE</title> To quantify new infection...
3.
Nahid P, Jarlsberg L, Kato-Maeda M, Segal M, Osmond D, Gagneux S, et al.
PLoS One . 2018 May; 13(5):e0195392. PMID: 29787561
Background: The roles of host and pathogen factors in determining innate immune responses to M. tuberculosis are not fully understood. In this study, we examined host macrophage immune responses of...
4.
Feng J, Jarlsberg L, Salcedo K, Rose J, Janes M, Lin S, et al.
Int J Tuberc Lung Dis . 2017 May; 21(7):766-773. PMID: 28513421
Setting: The impact of the genetic characteristics of Mycobacterium tuberculosis on the clustering of multidrug-resistant tuberculosis (MDR-TB) has not been analyzed together with clinical and demographic characteristics. Objective: To determine...
5.
Feng J, Jarlsberg L, Rose J, Grinsdale J, Janes M, Higashi J, et al.
Int J Tuberc Lung Dis . 2017 Apr; 21(5):509-516. PMID: 28399965
Background: The impact of demographic, clinical, and bacterial factors on new infection by Euro-American lineage Mycobacterium tuberculosis among contacts of patients with tuberculosis (TB) has not been evaluated. Objective: To...
6.
Alipanah N, Cattamanchi A, Menzies R, Hopewell P, Chaisson R, Nahid P
Int J Tuberc Lung Dis . 2016 Oct; 20(11):1522-1528. PMID: 27776595
Setting: Several recent trials evaluating 4-month fluoroquinolone (FQ) containing regimens found that none of the experimental regimens were non-inferior to standard 6-month therapy in treating patients with drug-susceptible pulmonary tuberculosis...
7.
Metcalfe J, Makumbirofa S, Makamure B, Sandy C, Bara W, Mason P, et al.
Int J Tuberc Lung Dis . 2016 Jun; 20(7):882-9. PMID: 27287639
Background: Patients at elevated risk of drug-resistant tuberculosis (TB) are prioritized for Xpert(®) MTB/RIF testing; however, the clinical usefulness of the test in this population is understudied. Design: From November...
8.
Iroezindu M, Ofondu E, Mbata G, van Wyk B, Hausler H, Dh A, et al.
Ann Med Health Sci Res . 2016 May; 6(2):120-8. PMID: 27213096
Background: Tuberculosis (TB) causes significant morbidity/mortality among human immunodeficiency virus-infected individuals in Africa. Reducing TB burden in the era of highly active antiretroviral therapy (HAART) is a public health priority....
9.
Choi J, Jarlsberg L, Grinsdale J, Osmond D, Higashi J, Hopewell P, et al.
Int J Tuberc Lung Dis . 2015 Apr; 19(5):582-8. PMID: 25868028
Setting: Immunosuppressive conditions have been associated with low sensitivity of interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB). However, no systematic analysis...
10.
Fair E, Miller C, Ottmani S, Fox G, Hopewell P
Int J Tuberc Lung Dis . 2015 Feb; 19(3):269-72. PMID: 25686131
There is a need for better utilization of program data for global tuberculosis (TB) control. Significant information could be gained from data collected by TB programs that could supplement traditional...